CDK7-IN-13 structure
|
Common Name | CDK7-IN-13 | ||
|---|---|---|---|---|
| CAS Number | 2765676-20-6 | Molecular Weight | 452.50 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C20H23F3N6OS | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of CDK7-IN-13CDK7-IN-13 is a potent inhibitor of CDK7. CDK7-IN-13 is a pyrimidinyl derivative compound. CDK7-IN-13 has the potential for the research of various cancers, especially the cancer with transcriptional dysregulation (extracted from patent CN114249712A, compound 1)[1]. |
| Name | CDK7-IN-13 |
|---|
| Description | CDK7-IN-13 is a potent inhibitor of CDK7. CDK7-IN-13 is a pyrimidinyl derivative compound. CDK7-IN-13 has the potential for the research of various cancers, especially the cancer with transcriptional dysregulation (extracted from patent CN114249712A, compound 1)[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C20H23F3N6OS |
|---|---|
| Molecular Weight | 452.50 |